Sodium phosphate

Phase 2Small molecule

SSheba Medical Center

Sodium phosphate is one of 26 small molecule programs targeting Pancreatitis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PancreatitisRecruiting

PancreatitisPhase 2

Recruiting

Competition

Competitive Landscape

33 competitors in Pancreatitis

#DrugCompanyPhaseTrials

Indocin

CCosette Pharmaceuticals, Inc.

Approved

23 2

Voltaren

Novartis

Approved

5 3

Cysteine Hydrochloride

Novartis

Approved

1 4

Doribax

Shionogi

Approved

—5

Nitrostat

VViatris Specialty LLC

Approved

1 6

Imuran

LLegacy Health System

Approved

1 7

Avycaz

PPhiladelphia Eye Associates

Approved

1 8

Acetadote

AArbor Pharmaceuticals, Inc.

Approved

—9

Esbriet

LLegacy Health System

Approved

—10

Trental

VValidus Pharmaceuticals

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2029

Phase 2Recruiting

Pancreatitis

NCT07681050

Clinical

Trials by Indication[1]

Colonoscopy4 trials

Efficacy, Safety and Tolerability of Split-dose of PEG Compared With NaP Solution for Colonoscopy Preparation: A Randomized, Controlled Trial

Completed·IInje University·Phase 3·NCT01229800·207 enrolled

Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy

Terminated·SSheba Medical Center·N/A·NCT00558376·23 enrolled

Randomized Controlled Trail of Polyethylene Glycol vs Sodium Phosphate for Colonic Cleansing of Colonoscopy

Completed·DDong Yang·Phase 4·NCT03817788·586 enrolled

Show 1 more trial

Randomized Trial Comparing Carbonated Drink With Water as a Solvent for Colonoscopy Solution

Completed·—·N/A·NCT04316858·2 enrolled

Safety and Efficacy2 trials

Study on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 70 Years Old

Recruiting·RRenJi Hospital·Phase 2·NCT06652906·8 enrolled

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

Completed·BBausch Health Americas, Inc.·Phase 4·NCT01427296·2,154 enrolled

Efficacy and Safety1 trial

Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing

Completed·LLaboratoires Mayoly Spindler·Phase 3·NCT01840553·461 enrolled

Screening1 trial

Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening

Completed·NNorgine·Phase 3·NCT00427089·360 enrolled

Phase II1 trial

MOVIPREP® Versus NaP Pivotal Phase III Study

Completed·NNorgine·Phase 3·NCT00322062·340 enrolled

6 more indications

Gastric Emptying1 trial

Measurement of Gastric Emptying During and After COLOKIT® Intake

Completed·LLaboratoires Mayoly Spindler·Phase 2·NCT01398098·30 enrolled

Bowel Preparation1 trial

Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure

Completed·RRegion Skane·Phase 3·NCT05726097·147 enrolled

Randomized Controlled Trial1 trial

A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy

Completed·QQueen's University·Phase 4·NCT00410215·315 enrolled

Intravenous1 trial

Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers

Unknown status·SSheba Medical Center·Phase 2/3·NCT01458873·20 enrolled

Chemotherapy1 trial

Intravenous Bicarbonate To Verify The Correct Position of IV Catheters in Oncological Patients Oncological Patients Receiving Chemotherapy

Unknown status·SSheba Medical Center·Phase 2/3·NCT01748097·100 enrolled

Pancreatitis1 trial

Phosphate in Acute Pancreatitis (PPP)

Recruiting·DDuke University·Phase 2·NCT07681050·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 15 trial records for Sodium phosphate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sodium phosphate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sodium phosphate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sheba Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SSheba Medical Center

Sodium phosphate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2029

Trials by Indication[1]

Colonoscopy4 trials

Safety and Efficacy2 trials

Efficacy and Safety1 trial

Screening1 trial

Phase II1 trial

Gastric Emptying1 trial

Bowel Preparation1 trial

Randomized Controlled Trial1 trial

Intravenous1 trial

Chemotherapy1 trial

Pancreatitis1 trial

References

Drug Info

Quick Facts

Related News